[ad_1]
The closed-end fund has vowed not to charge performance fees as it prepares to float on the New York stock exchange
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...